Using several different outcomes, however—including the separation of AD dementia from non‐AD neurodegenerative disorders and correlations with amyloid and tau PET—P‐tau217 has shown somewhat better performance than P‐tau181 (Janelidze et al, 2020b). The gene discussed is MAPT; the disease is Alzheimer disease.